BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3219799)

  • 1. Three cases of factor I deficiency: the effect of treatment with plasma.
    Møller Rasmussen J; Teisner B; Jepsen HH; Svehag SE; Knudsen F; Kirstein H; Buhl M
    Clin Exp Immunol; 1988 Oct; 74(1):131-6. PubMed ID: 3219799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of C3 and factor B in patients with congenital factor I deficiency.
    Rasmussen JM; Teisner B; Brandt J; Brandslund I; Gry H
    J Clin Lab Immunol; 1990 Feb; 31(2):59-67. PubMed ID: 1966986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation.
    Teisner B; Brandslund I; Grunnet N; Hansen LK; Thellesen J; Svehag SE
    J Clin Lab Immunol; 1983 Oct; 12(2):63-7. PubMed ID: 6606048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation during CAPD.
    Young GA; Kendall S; Brownjohn AM
    Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
    Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
    J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation in acute coronary syndromes.
    Iltumur K; Karabulut A; Toprak G; Toprak N
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis with reduced and with normal levels of complement in the blood. Clinical and genetic correlation.
    Trouillas P; Moindrot J; Betuel H; Quincy C; Aimard G; Devic M
    Rev Neurol (Paris); 1976 Oct; 132(10):684-704. PubMed ID: 1006010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE; Elmgreen J; Teisner B; Svehag SE
    Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
    Gyongyossy-Issa MI; McLeod E; Devine DV
    J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properdin deficiency in a family with fulminant meningococcal infections.
    Sjöholm AG; Braconier JH; Söderström C
    Clin Exp Immunol; 1982 Nov; 50(2):291-7. PubMed ID: 7151327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.
    Oren R; Laufer J; Goldberg I; Kopolovic J; Waldherr R; Passwell JH
    Immunology; 1995 Dec; 86(4):575-83. PubMed ID: 8567024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement studies in severe viral hepatitis of childhood.
    Dupuy C; Dupuy JM
    Pathol Biol (Paris); 1977 Oct; 25(8):553-8. PubMed ID: 339168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement and IgG subclasses in agammaglobulinemic patients.
    Grumach AS; Kirschfink M
    Exp Clin Immunogenet; 1995; 12(1):10-5. PubMed ID: 7710760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H.
    S Reis E; Falcão DA; Isaac L
    Scand J Immunol; 2006 Mar; 63(3):155-68. PubMed ID: 16499568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation in early protocol kidney graft biopsies after living-donor transplantation.
    Sund S; Hovig T; Reisaeter AV; Scott H; Bentdal Ø; Mollnes TE
    Transplantation; 2003 Apr; 75(8):1204-13. PubMed ID: 12717204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement abnormalities during an epidemic of group B meningococcal infection in children.
    Beatty DW; Ryder CR; Heese HD
    Clin Exp Immunol; 1986 Jun; 64(3):465-70. PubMed ID: 3491693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in complement breakdown products and terminal complement complex in patients with acute glomerulonephritis].
    Kojima H; Ohi H; Seki M; Hatano M
    Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):925-31. PubMed ID: 2585834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of hepatic necrosis and complement system activation in fulminant viral hepatitis].
    Hou J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):49-54. PubMed ID: 8324837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.
    Seghaye MC; Duchateau J; Grabitz RG; Faymonville ML; Messmer BJ; Buro-Rathsmann K; von Bernuth G
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):978-87. PubMed ID: 8246580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.